CABALETTA BIO, INC. (CABA): Price and Financial Metrics
CABA Price/Volume Stats
| Current price | $2.38 | 52-week high | $26.35 |
| Prev. close | $2.31 | 52-week low | $1.76 |
| Day low | $2.23 | Volume | 1,839,300 |
| Day high | $2.51 | Avg. volume | 1,426,631 |
| 50-day MA | $3.53 | Dividend yield | N/A |
| 200-day MA | $8.16 | Market Cap | 116.33M |
CABA Stock Price Chart Interactive Chart >
CABALETTA BIO, INC. (CABA) Company Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
CABA Price Returns
| 1-mo | 27.27% |
| 3-mo | -49.36% |
| 6-mo | -71.50% |
| 1-year | -89.25% |
| 3-year | -42.09% |
| 5-year | -82.45% |
| YTD | -89.52% |
| 2023 | 145.41% |
| 2022 | 144.06% |
| 2021 | -69.63% |
| 2020 | -10.67% |
| 2019 | N/A |
Loading social stream, please wait...